Literature DB >> 22590713

The prevalence and burden of primary headaches in China: a population-based door-to-door survey.

Shengyuan Yu1, Ruozhuo Liu, Gang Zhao, Xiaosu Yang, Xiangyang Qiao, Jiachun Feng, Yannan Fang, Xiutang Cao, Mianwang He, Timothy Steiner.   

Abstract

OBJECTIVES: In the absence of reliable data on the prevalence and burden of primary headache disorders in the mainland of China, a population-based survey was initiated by Lifting The Burden: the Global Campaign against Headache.
METHODS: Throughout all regions of China, 5041 non-related adult respondents aged 18-65 years were randomly sampled from the general population according to the expanded programme on immunization method established by World Health Organization. They were visited by door-to-door calling and surveyed using the structured questionnaire developed by Lifting The Burden, translated into Chinese and adapted to Chinese culture after a pilot study.
RESULTS: The responder rate was 94.1%.The estimated 1-year prevalence of primary headache disorders was 23.8% (95%confidence interval 22.6-25.0%), of migraine 9.3% (95% confidence interval 8.5-10.1%), of tension-type headache (TTH) 10.8%(9.9-11.6%), and of chronic daily headache (CDH) 1.0% (0.7-1.2%). Of respondents with migraine, TTH, and CDH, moderate or severe impact and therefore high need for effective medical care were reported by 38.0%, 23.1%, and 47.9%, respectively.The World Health Organization quality of life-8 questionnaire showed that all 3 types of headache reduced life quality. The total estimated annual cost of primary headache disorders, including migraine,TTH, and CDH was CNY 672.7 billion, accounting for 2.24% of gross domestic product (GDP) (direct cost: CNY 108.8 billion, 0.36% of GDP; indirect cost: CNY 563.9 billion, 1.88%of GDP).
CONCLUSION: The prevalence of primary headaches is high in China and not dissimilar from the world average. These headaches cause disability, impair work, study and daily activities, decrease life quality, and bring about a heavy and hitherto unrecognized socioeconomic burden.

Entities:  

Mesh:

Year:  2012        PMID: 22590713     DOI: 10.1111/j.1526-4610.2011.02061.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  123 in total

1.  Acupuncture treatment modulates the resting-state functional connectivity of brain regions in migraine patients without aura.

Authors:  Yong Zhang; Kuang-shi Li; Hong-wei Liu; Cai-hong Fu; Sheng Chen; Zhong-jian Tan; Yi Ren
Journal:  Chin J Integr Med       Date:  2015-04-06       Impact factor: 1.978

Review 2.  Medication-overuse headache: a perspective review.

Authors:  Maria Lurenda Westergaard; Signe Bruun Munksgaard; Lars Bendtsen; Rigmor Højland Jensen
Journal:  Ther Adv Drug Saf       Date:  2016-06-30

3.  The PACE study: lifetime and past-year prevalence of headache in Parma's adult general population.

Authors:  Arens Taga; Marco Russo; Gian Camillo Manzoni; Paola Torelli
Journal:  Neurol Sci       Date:  2017-02-17       Impact factor: 3.307

4.  Prevalence of headache and its interference in the activities of daily living in female adolescent students.

Authors:  Alaine Souza Lima; Rodrigo Cappato de Araújo; Mayra Ruana de A Gomes; Ludmila Remígio de Almeida; Gabriely Feitosa F de Souza; Samara Barreto Cunha; Ana Carolina R Pitangui
Journal:  Rev Paul Pediatr       Date:  2014-06

5.  The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients.

Authors:  Mina Abdolahi; Abbas Tafakhori; Mansoureh Togha; Ali Asghar Okhovat; Feridoun Siassi; Mohammad Reza Eshraghian; Mohsen Sedighiyan; Mona Djalali; Niyaz Mohammadzadeh Honarvar; Mahmoud Djalali
Journal:  Immunogenetics       Date:  2017-05-06       Impact factor: 2.846

Review 6.  Outcome of Chronic Daily Headache or Chronic Migraine.

Authors:  Soo-Jin Cho; Tae-Jin Song; Min Kyung Chu
Journal:  Curr Pain Headache Rep       Date:  2016-01

7.  Blockade of Nav1.8 currents in nociceptive trigeminal neurons contributes to anti-trigeminovascular nociceptive effect of amitriptyline.

Authors:  Jingyao Liang; Xiaoyan Liu; Meiyan Pan; Wei Dai; Zhao Dong; Xiaolin Wang; Ruozhuo Liu; Jianquan Zheng; Shengyuan Yu
Journal:  Neuromolecular Med       Date:  2013-11-30       Impact factor: 3.843

Review 8.  Ketoprofen for episodic tension-type headache in adults.

Authors:  Lucy Veys; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2016-09-22

Review 9.  Migraine in the era of precision medicine.

Authors:  Lv-Ming Zhang; Zhao Dong; Sheng-Yuan Yu
Journal:  Ann Transl Med       Date:  2016-03

Review 10.  Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults.

Authors:  Simon Law; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2016-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.